Bretschneider solution-induced alterations in the urine metabolome in cardiac surgery patients
Open Access
- 11 December 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 8 (1), 17774
- https://doi.org/10.1038/s41598-018-35631-w
Abstract
The development of Bretschneider’s histidine-tryptophan-ketoglutarate (HTK) cardioplegia solution represented a major advancement in cardiac surgery, offering significant myocardial protection. However, metabolic changes induced by this additive in the whole body have not been systematically investigated. Using an untargeted mass spectrometry-based method to deeply explore the urine metabolome, we sought to provide a holistic and systematic view of metabolic perturbations occurred in patients receiving HTK. Prospective urine samples were collected from 100 patients who had undergone cardiac surgery, and metabolomic changes were profiled using a high-performance chemical isotope labeling liquid chromatography-mass spectrometry (LC-MS) method. A total of 14,642 peak pairs or metabolites were quantified using differential 13C-/12C-dansyl labeling LC-MS, which targets the amine/phenol submetabolome from urine specimens. We identified 223 metabolites that showed significant concentration change (fold change > 5) and assembled several potential metabolic pathway maps derived from these dysregulated metabolites. Our data indicated upregulated histidine metabolism with subsequently increased glutamine/glutamate metabolism, altered purine and pyrimidine metabolism, and enhanced vitamin B6 metabolism in patients receiving HTK. Our findings provide solid evidence that HTK solution causes significant perturbations in several metabolic pathways and establish a basis for further study of key mechanisms underlying its organ-protective or potential harmful effects.This publication has 44 references indexed in Scilit:
- Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?Frontiers in Physiology, 2013
- Cardioprotection during cardiac surgeryCardiovascular Research, 2012
- Glutamine and glutathione at ICU admission in relation to outcomeClinical Science, 2012
- MetaboAnalyst: a web server for metabolomic data analysis and interpretationNucleic Acids Research, 2009
- Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/ReperfusionJournal of the American College of Cardiology, 2009
- Differential 12C-/13C-Isotope Dansylation Labeling and Fast Liquid Chromatography/Mass Spectrometry for Absolute and Relative Quantification of the MetabolomeAnalytical Chemistry, 2009
- Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac DeathAmerican Journal of Transplantation, 2009
- The Myocardial Protection of HTK Cardioplegic Solution on the Long-Term Ischemic Period In Pediatric Heart SurgeryASAIO Journal, 2008
- Bilateral internal mammary artery grafting: are BIMA better?Published by BMJ ,2002
- Comparison of Clinical Outcome Between Histidine-Triptophan-Ketoglutalate Solution and Cold Blood Cardioplegic Solution in Mitral Valve ReplacementJournal of Cardiac Surgery, 1998